Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury

Rhabdomyolysis (RM) is a clinical and laboratory syndrome accompanied by systemic endotoxicosis, a consequence of myocyte destruction and is manifested by acute kidney injury (AKI). The use of extracorporeal detoxification in the early stages of AKI is currently not recognized due to the lack of pro...

Full description

Bibliographic Details
Main Authors: S. V. Masolitin, M. A. Magomedov, T. G. Kim, I. N. Tyurin, V. M. Smetanina, E. Yu. Kalinin, D. N. Protsenko
Format: Article
Language:Russian
Published: New Terra Publishing House 2022-12-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
Online Access:https://www.vair-journal.com/jour/article/view/740
_version_ 1797696826715930624
author S. V. Masolitin
M. A. Magomedov
T. G. Kim
I. N. Tyurin
V. M. Smetanina
E. Yu. Kalinin
D. N. Protsenko
author_facet S. V. Masolitin
M. A. Magomedov
T. G. Kim
I. N. Tyurin
V. M. Smetanina
E. Yu. Kalinin
D. N. Protsenko
author_sort S. V. Masolitin
collection DOAJ
description Rhabdomyolysis (RM) is a clinical and laboratory syndrome accompanied by systemic endotoxicosis, a consequence of myocyte destruction and is manifested by acute kidney injury (AKI). The use of extracorporeal detoxification in the early stages of AKI is currently not recognized due to the lack of proven effectiveness.The objective: to demonstrate the effectiveness of selective hemoperfusion (HP) and hemodiafiltration (HDF) in a patient with toxic RM complicated by AKI.Subjects and methods. The article presents a clinical observation of an 18-year-old patient after the use of 4-methylmethcathinone (mephedrone) with development of AKI. Clinical, laboratory, diagnostic, toxicological and instrumental methods of examination were used. HP and HDF were used together with standard intensive therapy.Results. Combined use of HP and HDF was accompanied by regression of markers of endotoxicosis and AKI. A decrease in myoglobin level was noted by 50.3%, 80.3% and 94.1%, respectively, after the 1st and 2nd procedures and by the 5th day. CPK (creatine phosphokinase) decreased by 47.7%, 81.5% and 97.8%, respectively. Cystatin-C went down by 19.3%, 39.9% and 69.9%, respectively.Conclusions. Earlier and justified use of HP and HDF was accompanied by a rapid improvement of clinical and laboratory parameters, which is reflected in the duration of ICU stay, hospital stay and the outcome of the disease in general.
first_indexed 2024-03-12T03:31:44Z
format Article
id doaj.art-5c2afab84355412cba2fc2d5d259deca
institution Directory Open Access Journal
issn 2078-5658
2541-8653
language Russian
last_indexed 2024-03-12T03:31:44Z
publishDate 2022-12-01
publisher New Terra Publishing House
record_format Article
series Вестник анестезиологии и реаниматологии
spelling doaj.art-5c2afab84355412cba2fc2d5d259deca2023-09-03T13:24:42ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532022-12-01196788510.21292/2078-5658-2022-19-6-78-85565Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney InjuryS. V. Masolitin0M. A. Magomedov1T. G. Kim2I. N. Tyurin3V. M. Smetanina4E. Yu. Kalinin5D. N. Protsenko6Городская клиническая больница № 1 им. Н. И. ПироговаГородская клиническая больница № 1 им. Н. И. Пирогова; Российский национальный исследовательский медицинский университет им. Н. И. ПироговаГородская клиническая больница № 1 им. Н. И. ПироговаМосковский многопрофильный клинический центр «Коммунарка»; Российский национальный исследовательский медицинский университет им. Н. И. ПироговаМосковский многопрофильный клинический центр «Коммунарка»Городская клиническая больница № 1 им. Н. И. ПироговаМосковский многопрофильный клинический центр «Коммунарка»; Российский национальный исследовательский медицинский университет им. Н. И. ПироговаRhabdomyolysis (RM) is a clinical and laboratory syndrome accompanied by systemic endotoxicosis, a consequence of myocyte destruction and is manifested by acute kidney injury (AKI). The use of extracorporeal detoxification in the early stages of AKI is currently not recognized due to the lack of proven effectiveness.The objective: to demonstrate the effectiveness of selective hemoperfusion (HP) and hemodiafiltration (HDF) in a patient with toxic RM complicated by AKI.Subjects and methods. The article presents a clinical observation of an 18-year-old patient after the use of 4-methylmethcathinone (mephedrone) with development of AKI. Clinical, laboratory, diagnostic, toxicological and instrumental methods of examination were used. HP and HDF were used together with standard intensive therapy.Results. Combined use of HP and HDF was accompanied by regression of markers of endotoxicosis and AKI. A decrease in myoglobin level was noted by 50.3%, 80.3% and 94.1%, respectively, after the 1st and 2nd procedures and by the 5th day. CPK (creatine phosphokinase) decreased by 47.7%, 81.5% and 97.8%, respectively. Cystatin-C went down by 19.3%, 39.9% and 69.9%, respectively.Conclusions. Earlier and justified use of HP and HDF was accompanied by a rapid improvement of clinical and laboratory parameters, which is reflected in the duration of ICU stay, hospital stay and the outcome of the disease in general.https://www.vair-journal.com/jour/article/view/740рабдомиолизселективная гемосорбциягемодиафильтрацияострое почечное повреждениекомбинированная экстракорпоральная детоксикациямиоглобинцистатин-с
spellingShingle S. V. Masolitin
M. A. Magomedov
T. G. Kim
I. N. Tyurin
V. M. Smetanina
E. Yu. Kalinin
D. N. Protsenko
Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
Вестник анестезиологии и реаниматологии
рабдомиолиз
селективная гемосорбция
гемодиафильтрация
острое почечное повреждение
комбинированная экстракорпоральная детоксикация
миоглобин
цистатин-с
title Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
title_full Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
title_fullStr Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
title_full_unstemmed Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
title_short Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
title_sort use of selective hemosorption and hemodiafiltration in a patient with toxic rhabdomyolysis complicated by acute kidney injury
topic рабдомиолиз
селективная гемосорбция
гемодиафильтрация
острое почечное повреждение
комбинированная экстракорпоральная детоксикация
миоглобин
цистатин-с
url https://www.vair-journal.com/jour/article/view/740
work_keys_str_mv AT svmasolitin useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury
AT mamagomedov useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury
AT tgkim useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury
AT intyurin useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury
AT vmsmetanina useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury
AT eyukalinin useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury
AT dnprotsenko useofselectivehemosorptionandhemodiafiltrationinapatientwithtoxicrhabdomyolysiscomplicatedbyacutekidneyinjury